Please login to the form below

Not currently logged in
Email:
Password:

Lilly hires new ACE president

Eli Lilly & Company veteran, Andrew Hotchkiss, is to become the company's president for the Australia, Canada and Europe (ACE) region

Eli Lilly & Company veteran, Andrew Hotchkiss, is to become the company's president for the Australia, Canada and Europe (ACE) region.

Hotchkiss takes over from Karim Bitar, and will lead company activities across the region, as Lilly seeks to deliver innovative developments tackling illnesses such as diabetes, heart disease, mental health and cancer. 

Andrew Hotchkiss
Andrew Hotchkiss

Hotchkiss was most recently vice president and international business unit leader for Lilly Oncology.

"I am proud and excited to have the opportunity to lead Lilly's hugely talented pool of dedicated employees across the region, who are focused on the mission to help improve outcomes for patients," said Hotchkiss.

Bryce Carmine, executive vice president and president, Lilly Bio-Medicines, also commented on the appointment: "[Hotchkiss] will be a tremendous asset to the organisation in leading our efforts to maximise the value of our marketed products and prepare Lilly's ACE region for the next wave of innovative Lilly medicines."

9th June 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics